Can-Fite BioPharma Files 6-K, Incorporates Previous Filings
Ticker: CANF · Form: 6-K · Filed: Apr 15, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, compliance, registration-statement
TL;DR
Can-Fite BioPharma filed a 6-K, rolling previous S-8 and F-3 filings into it. Standard compliance.
AI Summary
On April 14, 2025, Can-Fite BioPharma Ltd. filed a Form 6-K report. This filing incorporates by reference previous registration statements on Form S-8 and Form F-3. The company is a foreign private issuer based in Israel, operating in the pharmaceutical preparations sector.
Why It Matters
This filing serves to update SEC filings and incorporate by reference previous registration statements, ensuring ongoing compliance and transparency for investors regarding the company's securities.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous documents and does not appear to contain new material information or significant changes.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer of the 6-K report
- 0001213900-25-031855.txt (document) — Accession number for the filing
- April 14, 2025 (date) — Date of the filing and incorporation by reference
- Form S-8 (document) — Type of registration statement incorporated by reference
- Form F-3 (document) — Type of registration statement incorporated by reference
FAQ
What is the purpose of this Form 6-K filing by Can-Fite BioPharma Ltd.?
The purpose of this Form 6-K is to report information as a foreign private issuer and to incorporate by reference the Company's Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on April 15, 2025, and pertains to the month of April 2025.
What are the file numbers for the Registration Statements incorporated by reference?
The incorporated Registration Statements include Form S-8 (File Nos. 333-227753, 333-271384, and 333-278525) and Form F-3 (File Nos. 333-236064, 333-274316, 333-262055, 333-276000, and 333-281872).
Where is Can-Fite BioPharma Ltd. located?
Can-Fite BioPharma Ltd. is located at 26 Ben Gurion Street, Ramat Gan, Israel.
Under which SEC Act is this filing made?
This filing is made under the Securities Exchange Act of 1934, pursuant to Rule 13a-16 or 15d-16.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2025 regarding Can-Fite BioPharma Ltd. (CANF).